Gilead agrees to settle Texas False Claims Act lawsuit over patient support programs
GILD•Gilead Sciences reached an agreement on October 22, 2026, to settle Texas False Claims Act litigation involving its patient support programs. The settlement requires a payment and dismissal with prejudice, while the company denies the allegations.
1. Settlement terms
The settlement requires a payment, dismissal with prejudice and release of all claims by Texas and Health Choice Advocates. Gilead said it settled to avoid the cost and distraction of prolonged litigation.
2. Programs to continue
Gilead said its patient support programs will remain available in Texas and across the United States.
